Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Giorgi

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1996
Assessing users' satisfaction through perception of usefulness and ease of use in the daily interaction with a hospital information systemM C Mazzoleni, P Baiardi, I Giorgi, et al.
European Journal of Medicinal Chemistry|August 26, 2000
5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. IG Biagi, V Calderone, I Giorgi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 20, 2000
[A project for the occupational reintegration of impaired subjects]E M Capodaglio, I Giorgi, P Capodaglio, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1990
Studies on 1,2,3-triazole derivatives as in vitro inhibitors of prostaglandin synthesisG Biagi, G Dell'Omodarme, M Ferretti, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 5, 2000
Outcome variables in the evaluation of alcoholics' treatment: lessons from the Italian Assessment of Alcoholism Treatment (ASSALT) ProjectG Corrao, V Bagnardi, A Zambon, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 5, 2002
Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. IIIG Biagi, V Calderone, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Synthesis of new N(6)-substituted 2-phenyl-8-azaadenosines. Their affinity for adenosine A1 and A2 receptors. A comparison with the corresponding 2-phenyl-9-benzyl-8-azaadenines. VIG Biagi, I Giorgi, O Livi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 23, 2007
[Anxiety and Depression Short Scale: norms for its use in rehabilitation]L Moroni, O Bettinardi, G Vidotto, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1994
N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IVG Biagi, I Giorgi, O Livi, et al.
European Journal of Medicinal Chemistry|December 21, 2000
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. IIB Baragatti, G Biagi, V Calderone, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1996
Assessing users' satisfaction through perception of usefulness and ease of use in the daily interaction with a hospital information systemM C Mazzoleni, P Baiardi, I Giorgi, et al.
European Journal of Medicinal Chemistry|August 26, 2000
5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. IG Biagi, V Calderone, I Giorgi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 20, 2000
[A project for the occupational reintegration of impaired subjects]E M Capodaglio, I Giorgi, P Capodaglio, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1990
Studies on 1,2,3-triazole derivatives as in vitro inhibitors of prostaglandin synthesisG Biagi, G Dell'Omodarme, M Ferretti, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 5, 2000
Outcome variables in the evaluation of alcoholics' treatment: lessons from the Italian Assessment of Alcoholism Treatment (ASSALT) ProjectG Corrao, V Bagnardi, A Zambon, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 5, 2002
Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. IIIG Biagi, V Calderone, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Synthesis of new N(6)-substituted 2-phenyl-8-azaadenosines. Their affinity for adenosine A1 and A2 receptors. A comparison with the corresponding 2-phenyl-9-benzyl-8-azaadenines. VIG Biagi, I Giorgi, O Livi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 23, 2007
[Anxiety and Depression Short Scale: norms for its use in rehabilitation]L Moroni, O Bettinardi, G Vidotto, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1994
N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IVG Biagi, I Giorgi, O Livi, et al.
European Journal of Medicinal Chemistry|December 21, 2000
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. IIB Baragatti, G Biagi, V Calderone, et al.
Pageof 9